喀麦隆耐药性癫痫手术的首个前瞻性队列结局
该单中心前瞻性单臂队列纳入31例2018年1月至2024年3月接受手术的耐药性癫痫患者,评估无发作率、认知变化与生活质量。12个月随访时71%达到无发作,总体生活质量评分显著提高,左侧与右侧切除的认知结局不同;作者认为在资源有限地区手术可行,但需更大样本与更长随访验证。
要点
- 31例耐药性癫痫患者术后12个月无发作率为71%。
- 左侧切除多数认知域下降,右侧切除多项指标改善。
- 无发作患者生活质量与神经心理表现更优,总体生活质量显著提升。
核心结论
- 在资源有限地区,对经选择的MRI可见、电临床一致且能完成术前评估的耐药性癫痫患者,癫痫手术可行并带来鼓舞的短期无发作与生活质量结局。
研究设计与样本
- 单中心、前瞻性、单臂队列,纳入2018年1月至2024年3月接受癫痫手术的31例耐药性癫痫患者。
- 主要终点为无发作(Engel IA-IB)、认知变化与生活质量改善;采用Kaplan-Meier分析自手术至致残性发作(Engel II-IV)的时间。
主要发现
- 女性占74%,手术时中位年龄21岁(IQR 14-29),中位病程8年(IQR 5-13)。
- 前颞叶切除术占61%,海马硬化是最常见病理(61%)。
- 12个月随访时71%达到无发作;13%出现一过性神经功能缺损,3.2%发生伤口感染。
- 认知结局按侧别不同:左侧切除多数认知域下降,右侧手术多项指标改善。
- 无发作患者在除精力水平与药物影响外的所有领域生活质量与神经心理表现更优(p<0.05);总体生活质量均分由6.4升至9.1(p<0.001),生活质量总分由49升至63(p<0.001),无发作者获益更大。
临床怎么用
- 对MRI可见病灶、电临床一致且能完成术前评估的耐药性癫痫患者,可考虑手术治疗。
- 术后应关注左侧切除患者的认知下降风险,并重视无发作对生活质量的带动作用。
局限性
- 单中心、单臂、样本量31例,随访时间短。
- 作者指出需更大规模多中心与更长随访研究以确定疗效的持久性与可推广性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to assess the quality of life and cognitive well-being of patients operated on for drug resistant epilepsy (DRE) in Cameroon. METHODS: We conducted a single-center, prospective single-arm cohort of 31 patients with DRE who underwent epilepsy surgery between January 2018 and March 2024. Primary endpoints were seizure freedom (Engel IA-IB), cognitive change, and quality of life (QoL) improvement. Survival estimates were computed using Kaplan-Meier analysis and assessed time from surgery to disabling seizure (Engel II-IV). RESULTS: In this cohort, female was predominant (74%), the median age at surgery was 21 years (IQR 14-29), and the median disease duration was 8 years (IQR 5-13). Anterior temporal lobectomy was performed in 61%; hippocampal sclerosis was the most common pathology (61%). At 12-month follow-up, 71% achieved seizure freedom. Postoperative complications were uncommon: 13% experienced transient neurologic deficits, and 3.2% had wound infections. Cognitive outcomes varied by laterality: left-side resections showed declines in most domains, whereas right-side surgeries demonstrated improvement in several measures. Seizure-free patients maintained better QoL and neuropsychological performance across all domains (p<0.05) except for energy level and medication effects. Overall QoL and sum QoL scores rose from a mean of 6.4 to 9.1 (p<0.001) and 49 to 63 (p<0.001), respectively, with significantly greater gains among seizure-free individuals. Kaplan-Meier analysis showed estimated freedom from disabling seizures of 74% (95% CI 55.0-86.2%) at 3 and 6 months and 71% (95% CI 51.6-83.7%) at 12 months. Median seizure-free survival was not reached. CONCLUSION: Epilepsy surgery was feasible in our resource-limited setting and was associated with encouraging short-term seizure and quality-of-life outcomes in carefully selected patients with MRI-visible, electroclinically concordant DRE who were able to complete presurgical evaluation. Larger multicentre studies with longer follow-up are needed to determine the durability and generalizability of these findings.
引用
- Guea Ngbwa G, Haman Nassourou O, Bekolo Nga E, et al. Pioneering Epilepsy Surgery in Cameroon: Outcomes from the First Prospective Cohort of Surgical Patients with Drug-Resistant Epilepsy. World Neurosurg. 2026. PMID: 42854952. doi:10.1016/j.wneu.2026.125407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。